DIO1
Basic information
Region (hg38): 1:53891239-53911086
Previous symbols: [ "TXDI1" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thyroid hormone metabolism, abnormal, 2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Endocrine | 32718224; 34128397 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DIO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 9 | 1 | 1 |
Variants in DIO1
This is a list of pathogenic ClinVar variants found in the DIO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-53894221-C-T | not specified | Uncertain significance (Sep 27, 2024) | ||
1-53894343-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
1-53894346-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
1-53894353-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
1-53894357-T-A | not specified | Likely benign (Nov 24, 2024) | ||
1-53894391-T-C | not specified | Uncertain significance (Dec 13, 2021) | ||
1-53894439-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
1-53894442-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
1-53894472-C-A | not specified | Uncertain significance (Apr 20, 2024) | ||
1-53894492-C-A | Thyroid hormone metabolism, abnormal, 2 | Pathogenic (Apr 26, 2022) | ||
1-53894498-G-A | Benign (Mar 29, 2018) | |||
1-53904716-A-C | not specified | Likely benign (Jun 27, 2022) | ||
1-53906118-A-G | not specified | Likely benign (Sep 02, 2024) | ||
1-53906119-T-C | not specified | Uncertain significance (Jun 03, 2022) | ||
1-53906216-G-A | Thyroid hormone metabolism, abnormal, 2 | Pathogenic (Apr 26, 2022) | ||
1-53906227-G-A | not specified | Uncertain significance (May 15, 2024) | ||
1-53906283-A-G | not specified | Uncertain significance (Dec 16, 2022) | ||
1-53909897-C-A | Levothyroxine response | drug response (-) | ||
1-53909934-A-G | not specified | Uncertain significance (Jul 27, 2024) | ||
1-53909964-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
1-53909970-C-T | not specified | Uncertain significance (Jan 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DIO1 | protein_coding | protein_coding | ENST00000361921 | 4 | 19848 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.584 | 0.414 | 125685 | 0 | 38 | 125723 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.479 | 127 | 143 | 0.887 | 0.00000773 | 1655 |
Missense in Polyphen | 38 | 55.973 | 0.6789 | 710 | ||
Synonymous | 0.198 | 52 | 53.8 | 0.966 | 0.00000290 | 473 |
Loss of Function | 2.56 | 2 | 11.3 | 0.177 | 5.68e-7 | 112 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000272 | 0.000272 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000272 | 0.000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Responsible for the deiodination of T4 (3,5,3',5'- tetraiodothyronine) into T3 (3,5,3'-triiodothyronine) and of T3 into T2 (3,3'-diiodothyronine). Plays a role in providing a source of plasma T3 by deiodination of T4 in peripheral tissues such as liver and kidney.;
- Pathway
- Thyroid hormone signaling pathway - Homo sapiens (human);Selenium Micronutrient Network;Selenium Metabolism and Selenoproteins;Regulation of thyroid hormone activity;Metabolism of amino acids and derivatives;Tyrosine metabolism;Metabolism;thyroid hormone metabolism II (via conjugation and/or degradation);thyroid hormone metabolism I (via deiodination);thyronamine and iodothyronamine metabolism;Thyroxine biosynthesis;Amine-derived hormones
(Consensus)
Intolerance Scores
- loftool
- 0.594
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.75
Haploinsufficiency Scores
- pHI
- 0.230
- hipred
- N
- hipred_score
- 0.199
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0720
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dio1
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; digestive/alimentary phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- thyroid hormone generation;thyroid hormone metabolic process;hormone biosynthetic process;oxidation-reduction process
- Cellular component
- endoplasmic reticulum membrane;plasma membrane;integral component of membrane
- Molecular function
- thyroxine 5'-deiodinase activity;selenium binding